Parkinson's Disease Trial, Recruiting NCT06542991 Sponsor: Anhui Medical University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06542991
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 years or older
  • People whose Parkinson's disease diagnosis meets the Movement Disorder Society standards
  • People whose Parkinson's medications have not been changed in the 4 weeks before the trial or during the treatment period
  • People whose motor symptom score (MDS-UPDRS III) is 8 or above, and whose disease stage falls between 1 and 4 on the Hoehn-Yahr scale (confirm with trial site)
  • People who score 24 or above on a standard memory and thinking test (MMSE), and are able to participate in behavioural tests and a brain stimulation treatment called transcranial magnetic stimulation

Who may not be able to join:

  • People whose brain MRI or CT scan shows a focal brain injury or severe white matter damage (Fazekas grade 3)
  • People with a form of parkinsonism caused by something other than Parkinson's disease, such as vascular causes, medication side effects, or other related conditions
  • People who have had a severe head injury, brain surgery, or deep brain stimulation treatment
  • People who have metal implants in their body, such as a cochlear implant or a heart pacemaker
  • People who have a personal or close family history of epilepsy, unexplained loss of consciousness, or who are currently taking medication to control seizures
  • People who have been diagnosed with a neurological or psychiatric condition other than Parkinson's disease
  • People with a history of drug abuse or recreational drug use
  • People who have taken part in another clinical trial within the past 6 months
  • Women who are pregnant or breastfeeding, or any person (including men) who plans to have a child within the next 6 months
  • People the trial investigators consider unsuitable for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 055162923704

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anhui Medical University
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale Part Ⅲ

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov